Healthcare provider profile · identity verified

Blessing Jerome, MD, DO, MPH

Internal Medicine · LAS VEGAS, NV · NPI 1235791377

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	735	270
Rosuvastatin Calcium	Rosuvastatin Calcium	478	180
Amlodipine Besylate	Amlodipine Besylate	393	153
Losartan Potassium	Losartan Potassium	381	143
Lisinopril	Lisinopril	334	121
Metformin Hcl	Metformin Hcl	276	112
Levothyroxine Sodium	Levothyroxine Sodium	230	75
Hydrochlorothiazide	Hydrochlorothiazide	189	75
Gabapentin	Gabapentin	178	77
Jardiance	Empagliflozin	178	54
Tamsulosin Hcl	Tamsulosin Hcl	165	68
Alendronate Sodium	Alendronate Sodium	140	51
Albuterol Sulfate Hfa	Albuterol Sulfate	137	59
Metoprolol Succinate	Metoprolol Succinate	133	47
Escitalopram Oxalate	Escitalopram Oxalate	123	52
Pantoprazole Sodium	Pantoprazole Sodium	120	48
Metformin Hcl Er	Metformin Hcl	118	48
Omeprazole	Omeprazole	112	44
Metoprolol Tartrate	Metoprolol Tartrate	98	41
Fluticasone Propionate	Fluticasone Propionate	94	42
Carvedilol	Carvedilol	92	31
Ozempic	Semaglutide	89	29
Furosemide	Furosemide	87	35
Tramadol Hcl	Tramadol Hcl	84	33
Glipizide Er	Glipizide	83	32
Montelukast Sodium	Montelukast Sodium	81	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	80	25
Trazodone Hcl	Trazodone Hcl	79	34
Eliquis	Apixaban	78	23
Simvastatin	Simvastatin	77	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	19
Atenolol	Atenolol	69	25
Allopurinol	Allopurinol	68	26
Potassium Chloride	Potassium Chloride	65	25
Famotidine	Famotidine	63	28
Zolpidem Tartrate	Zolpidem Tartrate	63	18
Glipizide	Glipizide	61	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	21
Nifedipine Er	Nifedipine	54	13
Clopidogrel	Clopidogrel Bisulfate	53	20
Ezetimibe	Ezetimibe	53	19
Pravastatin Sodium	Pravastatin Sodium	52	17
Duloxetine Hcl	Duloxetine Hcl	49	21
Triamcinolone Acetonide	Triamcinolone Acetonide	49	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	16
Methylprednisolone	Methylprednisolone	47	46
Sertraline Hcl	Sertraline Hcl	47	19
Azithromycin	Azithromycin	46	42
Farxiga	Dapagliflozin Propanediol	45	15
Hydralazine Hcl	Hydralazine Hcl	43	16
Methocarbamol	Methocarbamol	43	27
Mirtazapine	Mirtazapine	43	16
Pregabalin	Pregabalin	42	suppressed
Diclofenac Sodium	Diclofenac Sodium	39	24
Finasteride	Finasteride	39	14
Chlorthalidone	Chlorthalidone	34	14
Trulicity	Dulaglutide	34	12
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	30	suppressed
Prednisone	Prednisone	28	25
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	13
Sildenafil Citrate	Sildenafil Citrate	27	12
Valsartan	Valsartan	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	24
Meclizine Hcl	Meclizine Hcl	26	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	12
Baclofen	Baclofen	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Ibuprofen	Ibuprofen	24	16
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Alprazolam	Alprazolam	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Meloxicam	Meloxicam	17	11
Benazepril Hcl	Benazepril Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Ciclopirox	Ciclopirox	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	14
Irbesartan	Irbesartan	14	suppressed
Naproxen	Naproxen	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	13
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Amoxicillin	Amoxicillin	13	13
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	13	suppressed
Dapagliflozin	Dapagliflozin Propanediol	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Lactulose	Lactulose	12	suppressed
Topiramate	Topiramate	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error